Literature DB >> 11297695

A mutational analysis of the vaccinia virus B5R protein.

Elizabeth C Mathew1, Christopher M Sanderson1, Ruth Hollinshead1, Geoffrey L Smith1.   

Abstract

A mutational analysis of the vaccinia virus (VV) B5R protein is presented. This protein is related to the regulators of complement activation (RCA) superfamily, has four short consensus repeats (SCRs) that are typical of this superfamily and is present on extracellular enveloped virus (EEV) particles. Here we have constructed VV mutants in which the cytoplasmic tail (CT) of the B5R protein is progressively truncated, and domains of the B5R protein [the SCR (short consensus repeat) domains, the transmembrane anchor region or the CT] are substituted by corresponding domains from the VV haemagglutinin (HA), another EEV protein. Analysis of these mutant viruses showed that loss of the B5R CT did not affect the formation of intracellular enveloped virus (IEV), actin tails, EEV or virus plaque size. However, if the SCR domains of the B5R protein were replaced by the corresponding region of the HA, the virus plaque size was diminished, the formation of actin tails was decreased severely and the titre of infectious EEV released from cells was reduced approximately 25-fold compared to wild-type virus and 5-fold compared to a virus lacking the entire B5R gene. Thus the linkage of HA to the B5R transmembrane and CT is deleterious for the formation and release of EEV and for cell-to-cell virus spread. In contrast, deletion or substitution of the B5R CT did not affect virus replication, although the amount of cell surface B5R was reduced compared to control.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297695     DOI: 10.1099/0022-1317-82-5-1199

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

1.  Identification of second-site mutations that enhance release and spread of vaccinia virus.

Authors:  Ehud Katz; Elizabeth Wolffe; Bernard Moss
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Mutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein.

Authors:  Ehud Katz; Brian M Ward; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

3.  Aptamers recognizing glycosylated hemagglutinin expressed on the surface of vaccinia virus-infected cells.

Authors:  Parag Parekh; Zhiwen Tang; Peter C Turner; Richard W Moyer; Weihong Tan
Journal:  Anal Chem       Date:  2010-10-15       Impact factor: 6.986

4.  The vaccinia virus B5 protein requires A34 for efficient intracellular trafficking from the endoplasmic reticulum to the site of wrapping and incorporation into progeny virions.

Authors:  Amalia K Earley; Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

5.  Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins.

Authors:  Beatriz Perdiguero; Rafael Blasco
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.

Authors:  Lydia Aldaz-Carroll; J Charles Whitbeck; Manuel Ponce de Leon; Huan Lou; Lauren Hirao; Stuart N Isaacs; Bernard Moss; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  Vaccinia virus B5 protein affects the glycosylation, localization and stability of the A34 protein.

Authors:  Adrien Breiman; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2010-03-03       Impact factor: 3.891

8.  Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane.

Authors:  Kim L Roberts; Adrien Breiman; Gemma C Carter; Helen A Ewles; Michael Hollinshead; Mansun Law; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

9.  Vaccinia virus A34 glycoprotein determines the protein composition of the extracellular virus envelope.

Authors:  Beatriz Perdiguero; María M Lorenzo; Rafael Blasco
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

10.  MHV68 complement regulatory protein facilitates MHV68 replication in primary macrophages in a complement independent manner.

Authors:  Vera L Tarakanova; Jerome M Molleston; Megan Goodwin; Herbert W Virgin
Journal:  Virology       Date:  2009-11-11       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.